BioMark Diagnostics, Inc. (BUX.CX)
0.64
+0.06
(+10.34%)
CAD |
CNSX |
Mar 03, 16:00
BioMark Diagnostics Shareholders Equity (Quarterly) : 0.508M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Justera Health Ltd. | -3.726M |
| Neural Therapeutics, Inc. | -- |
| ARCpoint, Inc. | -10.42M |
| Arch Biopartners, Inc. | -3.882M |
| Biocure Technology, Inc. | 1.604M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.136M |
| Debt to Equity Ratio | 1.401 |
| Current Ratio | 1.197 |
| Net Debt Paydown Yield | -0.03% |